Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Source:http://linkedlifedata.com/resource/pubmed/id/11072167

Int. J. Radiat. Oncol. Biol. Phys. 2000 Nov 1 48 4 1089-96

Download in:

View as

General Info

PMID
11072167